How the COVID-19 Pandemic Changed Multimorbidity Care

What did physicians experience when managing multimorbidity during COVID-19?

The longitudinal qualitative study followed physician experiences across the COVID-19 pandemic rather than measuring the effectiveness of a particular drug or clinical protocol. This approach can reveal how clinical priorities, working conditions and care relationships change over time. For patients with multimorbidity, disruptions can be especially consequential because treatment commonly involves several medicines, clinicians and monitoring schedules.

Emergency demands during the pandemic competed with routine management of conditions such as diabetes, cardiovascular disease and chronic respiratory illness. Physicians also had to weigh infection risks against the harms of delayed examinations, laboratory monitoring or medication adjustment. The findings should be interpreted as context-specific professional experiences, but they can help health systems identify weaknesses that conventional outcome statistics may not fully explain.

Why is multimorbidity difficult to manage during a health-system crisis?

Multimorbidity generally means that one person has at least two long-term health conditions. Clinical decisions cannot always be made by applying separate guidelines for each disease because recommendations may conflict or create an excessive treatment burden. Polypharmacy can increase the need to review interactions, adverse effects and whether each medicine still supports the patient’s priorities.

A crisis can magnify these problems by interrupting appointments, diagnostic services and medicine access. Remote consultations may preserve contact for some patients, but they cannot replace every physical examination or investigation. People with limited digital access, complex symptoms or unstable disease may require carefully prioritized in-person assessment and clear instructions about when to seek urgent help.

How can health systems make chronic disease care more resilient?

International guidance on integrated, people-centered care emphasizes coordination around the individual rather than organizing every encounter around a single diagnosis. Practical measures include assigning responsibility for overall care, reconciling medication lists, documenting patient goals and ensuring that referrals and test results reach all relevant clinicians. Longer prescriptions or alternative collection arrangements may help selected stable patients when routine access is threatened.

Preparedness plans should also distinguish care that can safely be delayed from monitoring that is time-sensitive. Health services can use telephone or video follow-up where appropriate while maintaining pathways for examination, laboratory testing and urgent escalation. Qualitative evidence from clinicians can complement patient reports and health-service data, helping planners understand not only whether care was interrupted but also how and why disruption occurred.